With increased reporting of corruption in the Middle East and the desire to attract foreign direct investment, governments across the region are under pressure to align with international best practice and to further regulate and enforce. The healthcare sector is no exception, and market players may thus have to change their business practices.

Baker McKenzie Habib Al Mulla invites you to an interactive workshop in Dubai around the current market environment and emerging compliance issues for those operating in the healthcare sector in the Middle East, particularly in the UAE, Saudi Arabia and Egypt. Industry experts from Johnson & Johnson and Merck will join our lawyers in highlighting key risk areas companies should be alert to, drawing from EU and US best practices and giving practical guidance on issues such as:

  • anti-bribery trends in the healthcare sector across the region;
  • interaction with healthcare professionals (including sponsorship and fair market value); and
  • direct patient interaction and patient support programs (including data privacy, informed consent and e-health).

This workshop is FREE of charge and we hope you will be able to join us. If you have any queries, kindly contact Jenny Medina.

Date & Time

26 February 2018 | 8:30 am to 10:30 am (Gulf Standard Time)


The Capital Club
Gate Village, Building 3
Dubai International Financial Centre
Dubai, UAE
View on Google Maps

8:30 am Registration
9:00 am Workshop
10:30 am Wrap-up

One-to-one meetings

Our lawyers will be available for one-to-one meetings in Dubai on 26 & 28 February and in Abu Dhabi on 27 February to discuss specific compliance issues you may have. Please contact UAE.BD@bakermckenzie.com if you wish to set up a personal appointment as the number of meetings will be limited.

Previous articleBaker McKenzie releases 4th Edition of Global Product Recall Handbook
Next articleSingapore’s New Cybersecurity Act – A Relief and Leading the Way for Others?